Safety
Setmelanotide
Adverse-event report summary for Setmelanotide, drawn from the FDA Adverse Event Reporting System (FAERS).
- Total reports
- 58
- Reports flagged serious
- 53
“Serious” is FAERS’s own report-level flag (e.g. death, hospitalization, or another outcome the reporter marked as serious) and does not indicate a verified or compound-caused outcome.
Most frequently reported reactions
- Nausea22 reports
- Skin Discolouration16 reports
- Headache14 reports
- Skin Hyperpigmentation14 reports
- Vomiting14 reports
- Weight Increased14 reports
- Fatigue13 reports
- Diarrhoea11 reports
- Hospitalisation11 reports
- Hunger11 reports
- Illness11 reports
- Product Dose Omission Issue11 reports
- Abdominal Pain Upper9 reports
- Injection Site Erythema9 reports
- Injection Site Pain9 reports
Counts reflect the most-reported reaction terms (MedDRA preferred terms) associated with reports naming this compound. A single report can list multiple reactions, so reaction counts need not sum to the total number of reports.